DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 153 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2018. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $604,000 | +60.2% | 105,573 | 0.0% | 0.06% | +53.7% |
| Q3 2019 | $377,000 | -10.5% | 105,573 | 0.0% | 0.04% | -8.9% |
| Q2 2019 | $421,000 | -45.5% | 105,573 | 0.0% | 0.04% | -44.4% |
| Q1 2019 | $772,000 | -20.1% | 105,573 | 0.0% | 0.08% | -25.7% |
| Q4 2018 | $966,000 | -50.0% | 105,573 | -32.2% | 0.11% | -44.4% |
| Q3 2018 | $1,931,000 | -3.2% | 155,755 | +19.1% | 0.20% | -10.5% |
| Q2 2018 | $1,994,000 | -7.6% | 130,755 | +20.2% | 0.22% | -13.8% |
| Q1 2018 | $2,159,000 | +6.1% | 108,755 | 0.0% | 0.25% | +5.8% |
| Q4 2017 | $2,034,000 | -13.0% | 108,755 | 0.0% | 0.24% | -20.5% |
| Q3 2017 | $2,338,000 | +189.4% | 108,755 | +29.8% | 0.30% | +177.1% |
| Q2 2017 | $808,000 | +171.1% | 83,755 | +67.5% | 0.11% | +159.5% |
| Q1 2017 | $298,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |